These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 4627254

  • 21. [Stimulation of TSH secfetion by TRF load in hypothalamic and pituitary diseases].
    Pickardt CR, Geiger W, Fahlbusch R, Scriba PC.
    Klin Wochenschr; 1972 Jan 01; 50(1):42-52. PubMed ID: 4621744
    [No Abstract] [Full Text] [Related]

  • 22. Pituitary deficiency in patients with pituitary tumours.
    Martin FI.
    Australas Ann Med; 1966 Feb 01; 15(1):40-50. PubMed ID: 5913242
    [No Abstract] [Full Text] [Related]

  • 23. Serum thyrotropin (TSH) in pituitary and-or hypothalamic hypothyroidism: normal or elevated basal levels and paradoxical responses to thyrotropin-releasing hormone.
    Patel YC, Burger HG.
    J Clin Endocrinol Metab; 1973 Aug 01; 37(2):190-6. PubMed ID: 4352630
    [No Abstract] [Full Text] [Related]

  • 24. Effect of synthetic thyrotropin-releasing factor (TRF) on pituitary TSH secretion in man.
    Sakoda M, Otsuki M, Hiroshige N, Kanao K, Yagi A.
    Endocrinol Jpn; 1970 Dec 01; 17(6):541-9. PubMed ID: 4996357
    [No Abstract] [Full Text] [Related]

  • 25. [Pituitary function test using synthetic lysine-8-vasopressin--comparison with metopirone test and insulin stress test].
    Nishida S, Nakajima T.
    Naika; 1971 Dec 01; 28(1):157-62. PubMed ID: 4327699
    [No Abstract] [Full Text] [Related]

  • 26. [Effects of TSH releasing factor (TRH) and LH releasing factor (LH-RH) in hypopituitarism].
    Chaussain JL, Garnier PE, Milhaud G, Job JC.
    Ann Med Interne (Paris); 1972 Dec 01; 123(12):1041-6. PubMed ID: 4198073
    [No Abstract] [Full Text] [Related]

  • 27. [Effects of synthetic TRH on human prolactin (HPr) secretion].
    Kato Y, Ogo S, Chihara K, Imura H.
    Nihon Naibunpi Gakkai Zasshi; 1973 Sep 20; 49(9):1215-22. PubMed ID: 4201607
    [No Abstract] [Full Text] [Related]

  • 28. [The diagnostic significance of synthetic LH-RH (luteinizing hormone-releasing hormone) in evaluating gonadotropic pituitary function (author's transl)].
    Solbach HG, Wiegelmann W, Kley HK, Zimmermann H, Krüskemper HL.
    Dtsch Med Wochenschr; 1973 Nov 09; 98(45):2114-9. PubMed ID: 4585937
    [No Abstract] [Full Text] [Related]

  • 29. Clinical features of nonfunctioning chromophobe adenomas.
    Hooper MJ, Stiel JN, Selby G, Grant JM, Watters S.
    Aust N Z J Med; 1973 Aug 09; 3(4):371-5. PubMed ID: 4519124
    [No Abstract] [Full Text] [Related]

  • 30. The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa.
    Landon J, Greenwood FC, Stamp TC, Wynn V.
    J Clin Invest; 1966 Apr 09; 45(4):437-49. PubMed ID: 5949228
    [No Abstract] [Full Text] [Related]

  • 31. [Visual function disorders associated with tumors of the hypothalamo-hypophyseal region with reactive optochiasmal arachnoiditis].
    Stroganova EI.
    Vopr Neirokhir; 1971 Apr 09; 35(2):14-8. PubMed ID: 5570268
    [No Abstract] [Full Text] [Related]

  • 32. Clinical endocrinological approach to hypothalamic-pituitary disease.
    Abboud CF, Laws ER.
    J Neurosurg; 1979 Sep 09; 51(3):271-91. PubMed ID: 381598
    [Abstract] [Full Text] [Related]

  • 33. Abnormalities in the release of TSH in response to thyrotropin-releasing hormone (TRH) in patients with disorders of the pituitary, hypothalamus and basal ganglia.
    Schalch DS, Gonzalez-Barcena D, Kastin AJ, Schally AV, Lee LA.
    J Clin Endocrinol Metab; 1972 Oct 09; 35(4):609-15. PubMed ID: 4626446
    [No Abstract] [Full Text] [Related]

  • 34. [Secondary anemorrhea in processes in the sella region].
    Synowitz HJ, Siedschiag WD.
    Zentralbl Gynakol; 1975 Oct 09; 97(11):656-60. PubMed ID: 171883
    [Abstract] [Full Text] [Related]

  • 35. [The prolactin and TSH response to stimulation in patients with hypophyseal tumors].
    Suchmanová I, Trejbal D, Trejbalová L, Mechír J, Pokorná I, Machánová Y.
    Cas Lek Cesk; 1990 Mar 23; 129(12):361-3. PubMed ID: 2111223
    [Abstract] [Full Text] [Related]

  • 36. [DIAGNOSIS AND NEUROSURGICAL TREATMENT OF HYPOPHYSEAL TUMORS. REVIEW OF THE STATISTICS].
    HERREMAN R, REYESARMIJO E.
    Rev Med Hosp Gen (Mex); 1964 Mar 23; 27():137-49. PubMed ID: 14153047
    [No Abstract] [Full Text] [Related]

  • 37. [Behavior of plasmatic TSH in pituitary neoplasms after stimulation with thyrotropin releasing hormone (TRH)].
    Silvestrini F, Liuzzi A, Chiodini PG, Cattabeni A, Botalla L.
    Folia Endocrinol; 1973 Oct 23; 26(5):398-406. PubMed ID: 4203133
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Basal interhemispheric supra- and/or infrachiasmal approaches via superomedial orbitotomy for hypothalamic lesions: preservation of hypothalamo-pituitary functions in combination treatment with radiosurgery.
    Inoue HK, Fujimaki H, Kohga H, Ono N, Hirato M, Ohye C.
    Childs Nerv Syst; 1997 May 23; 13(5):250-6. PubMed ID: 9224913
    [Abstract] [Full Text] [Related]

  • 40. [Effects of synthetic thyrotropin-releasing factor (TRF) on TSH secretion with special reference to the evaluation of the TRF test].
    Otsuki M.
    Nihon Naibunpi Gakkai Zasshi; 1971 Aug 20; 47(5):301-21. PubMed ID: 4105899
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.